Psychedelic scams of large tech companies | Wired

But with all due respect, we have crossed the Rubicon.The latest signs indicate that psychedelics are not just medical, when Mark Haden of MAPS Canada appeared on Netflix Sticky Lab And nodded sympathetically, because (now the former) Chief Content Officer Elise Loehnen talked about the goop staff in Jamaica mushrooming to “feel more creative” or “get a mental and spiritual experience.” Whenever they let the chief operating officer act as a spokesperson and complain about company corruption on their behalf, the doctors will allow this mission to spread.

Although their profits Depends on convincing you that you need a professional-a professional them Employment-It turns out that most of these entrepreneurs believe that if there is no such detailed and expensive agreement, they have healed.

In interviews after interviews, the big names behind these clinics and research companies talked about taking psychedelics in non-medical settings and/or for personal growth reasons—they reaped the benefits anyway. Joe Green, the entrepreneur who helped MAPS raise $30 million, Tell this Wall Street Journal His experience with psychedelics helped him “rediscover the miracle.” Dylan Beynon, founder of Ketamine Clinic Heart blooms, Tell the blog Eight sleep After a friend recommended him to try MDMA, he became interested in psychedelics.Similarly, a investor Psilocybin was recommended to Lars Wilde, a serial entrepreneur who co-founded Compass Pathways with George Goldsmith. (The main funders of Compass include Peter Thiel and investor Christian Angermayer, their first travel With friends on a beach in the Caribbean. ) Presumably, none of these investor friends are part-time MDs.

Therefore, if these people are safely enjoying the benefits of psychedelics in a healthy environment, then why take the medical route? Why not go all out? First, the underground psychedelic drug market already exists, and immutable spiritual suitors are unlikely to care too much about whether the FDA has approved a drug, so they do not represent an untapped source of profit. But crucially, except for a few states, it is unlikely that psychedelic drugs will be legalized for widespread consumption in the short term, so using drugs as a backdoor allows technology companies to take advantage of emerging markets before anyone else. .

Taking into account the ketamine infusion plus medical supervision plus hours of “processing”, by leaving these drugs at the gates of their control, they ensure that certain types of customers are most likely to enter-with disposable income or very good The cost of an insured therapist is much higher than that of pills on the street-and people who have historically been denied access to good health care or who have been disproportionately punished for drug use (ie the poor) will be rejected. In this way, they can attract potential customers who may be afraid of risks, or potential customers who associate drug use with depravity and dependence, and their hesitation will be reduced by medical clearance.

Of course, parties occasionally mention “democratizing” their services, but this is part of their long-term utopian scam. Over time, their desire for monopoly inevitably surfaced.For example, David Bronner, his supporter Oregon Act To legalize psilocybin in a therapeutic setting, recently defendant Compass is trying to “mobilize against” the legalization approach, so Compass can better control the market by being the only company providing services. (The CEO of Compass told Vice that he “just wanted to have a dialogue on the bill.”)

Of all the groups that define mental health and tell you how to achieve it, you can hardly find a group that is worse than a wealthy white technician. Their obsession with global connectivity has made many of us more emotionally alienated (ironically, they can view “disconnection” as a symptom of depression, making them mentally healthy for firefighter arsonists problem). The ubiquity of social media shows us the dark side of self-optimization and how platforms arrogantly treat individual user data. In the end, their prioritization of growth over management means that the company tends to swell before it is hollowed out, leaving behind a series of exhausted, deprived employees and dissatisfied users. When you work with disadvantaged groups, this indicates bad news.Many previous attempts at mental health care have been compromised by scandals and inefficiencies. Companies like this Conversation space Accused of opaque and unethical behavior, and other similar good helper A more benign sin with over-commitment-an amazing therapist, available 24/7! -Insufficient delivery with a robot that is not always responsive.

Psychedelics missed We only follow us for the barbaric reasons of capitalism.Many people are suffering, and there are psychedelic drugs were able Fundamentally change the way people think and lead to meaningful personal growth, sometimes after only one use-I think I belong to those who have a positive experience. It is important that we give people who feel they would benefit from psychedelic drugs the option to try them.

But instead of giving the reins to a group that has long corrupted our collective mental and mental health, how about listening to those who have experience in treating people with psychedelics? If we want to respect the idea of ​​psychedelics by indigenous communities for thousands of years-to be fair, there have been some attempts to do so, but usually symbolically-then we will turn to psychedelic practitioners, Doula and For fear of being sued, many of them have worked underground for many years.

Ideally, we will work hard to make people decide on their own to legalize, standardize, and legalize the recreational use of psychedelics, and educate individuals on how to make themselves safe and enjoyable travel.The implementation of this policy change will be real The revolution we need.

Source link

Recommended For You

About the Author: News Center